MedPath

Kidney Uptake at F-18 FDG PET/CT Studies and Renal Function Status

Not yet recruiting
Conditions
Renal Uptake at F-18-FDG PET/CT
Interventions
Device: PET/CT
Registration Number
NCT06268067
Lead Sponsor
Assiut University
Brief Summary

Searching for a possible correlation between renal uptake at F-18-FDG PET/CT and renal functional parameters in both normal subjects and patients with CKD.

Detailed Description

F-18-Fluoro-Deoxy-Glucose Positron Emission Tomography (F-18 FDG PET/CT) is a hybrid imaging modality that in the last few years has been gaining more attention, due to its ability for evaluation different conditions, both neoplastic or benign. In the urinary tract, FDG is filtered by the glomerulus and is not reabsorbed by the renal tubules. So, significant activity may be displayed in any part of the urinary tract. Chronic kidney disease is highly prevalent and associated with higher cardiovascular risk. CKD is diagnosed when an estimated glomerular filtration rate (EGFR) lower than 60 mL/min/1.73 m2 present for at least three months or by alteration in the renal structure\[3\]. The Kidney Disease: Improving Global Outcomes (KDIGO) CKD guidelines recommend use of the EGFR for determination of the disease because of its simplicity, cost-effectiveness, and accuracy in predicting renal function in standard conditions. The estimating equation for the assessment of EGFR in adults is the CKD Epidemiology Collaboration (CKD-EPI).

In some cases, it has been reported that the impairment of renal function doesn't significantly compromise the clearance of background activity of F-18-FDG. In contrast, other papers observed that CKD patients have a higher physiological tracer uptake in the liver and blood pool. Different studies investigated the ability of CKD in modification of the F-18-FDG uptake during a PET/CT scan have also been published with contradictory results.

Therefore, we search for the association between renal uptake at F-18-FDG PET/CT and renal functional parameters in both normal subjects and CKD patients.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
97
Inclusion Criteria
  • Adult patients undergoing PET/CT examination for oncologic or non-oncologic purposes.
Exclusion Criteria
  • Patients underwent PET/CT examination with age under 18 years.
  • Presence of pathological conditions affecting kidneys (e.g., cancers, inflammation, polycystic kidney disease)
  • Inability to stay still for the duration of the scan.
  • Claustrophobia.
  • Patients with uncontrolled diabetics (blood glucose >200 mg/dl immediately before PET/CT scan)
  • Pregnant females.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chronic kidney diseased patiensPET/CTchronic kidney diseased patients
NormalPET/CTnormal subjects
Primary Outcome Measures
NameTimeMethod
significance of renal uptake at F18-FDG PET CT studiesone year

The study assesses the significance of renal uptake at F18-FDG PET CT studies as regards Cr levels and EGFR.

Secondary Outcome Measures
NameTimeMethod
Early detection of patients with CKDone year

• Early detection of patients with CKD to initiate appropriate treatment for them, with subsequently improving the survival and quality of life.

© Copyright 2025. All Rights Reserved by MedPath